LJUBLJANA, Nov 6 (Reuters) - Slovenian generic drugs maker
Krka KRKG.LJ posted a nine-month group net profit of 127.4
million euros ($159 million), up 2 percent from the same period
in 2013, and it expected full-year profit to be level with last
year, it said on Thursday.
Last year's net profit was 172.8 million euros. Krka said
the figure would remain unchanged in 2015 as well.
The company said annual sales would be about 1.2 billion
euros, below Krka's earlier forecast of 1.25 billion. Nine-month
sales totalled 858 million euros, unchanged from last year, due
to the lower prices of drugs and currency risks.
(1 US dollar = 0.7989 euro)
(Reporting By Marja Novak; Editing by Zoran Radosavljevic and
Susan Thomas)
((Marja.Novak@thomsonreuters.com; +386-8-205-6369; Reuters
Messaging: marja.novak.thomsonreuters.com@reuters.net))
Keywords: KRKA RESULTS/